Literature DB >> 10910804

Irritable bowel syndrome and mirtazapine.

S G Thomas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10910804     DOI: 10.1176/appi.ajp.157.8.1341-a

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  7 in total

1.  Treatment of Functional GI Disorders With Psychotropic Medicines: A Review of Evidence With a Practical Approach.

Authors:  Syed I M Thiwan; Douglas A Drossman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-09

2.  Open-label treatment with citalopram in patients with irritable bowel syndrome: a pilot study.

Authors:  Prakash S Masand; Sanjay Gupta; Thomas L Schwartz; Subhdeep Virk; Ahmad Hameed; David S Kaplan
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

3.  Effect of Oral Intake of Lactiplantibacillus plantarum APsulloc 331261 (GTB1TM) on Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study.

Authors:  Kyoungmi Jung; Areum Kim; Ji-Hae Lee; Donghyun Cho; Juyeon Seo; Eun Sung Jung; Hye-Ji Kang; Jonghwa Roh; Wangi Kim
Journal:  Nutrients       Date:  2022-05-11       Impact factor: 6.706

4.  Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: superiority over imipramine.

Authors:  Eylem Sahin Cankurtaran; Elvan Ozalp; Haldun Soygur; Derya Iren Akbiyik; Levent Turhan; Necati Alkis
Journal:  Support Care Cancer       Date:  2008-02-26       Impact factor: 3.603

Review 5.  The interface of psychiatry and irritable bowel syndrome.

Authors:  David G Folks
Journal:  Curr Psychiatry Rep       Date:  2004-06       Impact factor: 5.285

6.  Paroxetine in Patients With Irritable Bowel Syndrome: A Pilot Open-Label Study.

Authors:  Prakash S. Masand; Sanjay Gupta; Thomas L. Schwartz; Subhdeep Virk; Kari Lockwood; Ahmad Hameed; Monica King; David S. Kaplan
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2002-02

Review 7.  Current perspectives on irritable bowel syndrome: a narrative review.

Authors:  Mariko Hojo; Akihito Nagahara
Journal:  J Int Med Res       Date:  2022-09       Impact factor: 1.573

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.